
WASHINGTON, DC — No state has taken advantage of guidance from the Centers for Medicare and Medicaid Services that allows them to offer leaner, cheaper plans that discriminate against patients with preexisting conditions, but it isn’t stopping Senate Democrats from forcing a vote on the issue.

U.S. Sen. Chris Murphy joined a conference call Tuesday with Senate Democratic Leader Chuck Schumer of New York and U.S. Senator Mark Warner of Virginia to call for an end to the rule.
The trio said the Trump administration’s rule, if left in place, allows states to greenlight junk insurance plans that don’t fully protect people with pre-existing conditions, don’t cover essential health benefits like prescription drugs and maternity care, and raise out-of-pocket costs on many American families.
“I’m glad that we’re going to have a chance to vote on this,” Murphy said Tuesday. “I’ve been listening to my Republican colleagues say for years and years that though they don’t love everything about the Affordable Care Act, they want to protect people with pre-existing conditions. Well, here’s their chance.”
Schumer plans to use a law that allows Congress to undo regulations with a simple majority. By using the Congressional Review Act, Senate Democrats can force a floor vote on a resolution overturning the administration’s guidance on 1332 waivers.
“They can take a vote, this week, that protects coverage and rates for people with pre-existing conditions and we’ll see what they choose,” Murphy said.
The 1332 waivers have mostly been used for reinsurance programs, like the one the state of Connecticut is considering.
Traditionally, reinsurance programs under the 1332 waiver help insurers cover the costs for their most expensive patients, which then allows insurers to lower overall monthly premiums for everyone else.
Maryland, Wisconsin, Maine, New Jersey, Minnesota, Oregon and Alaska all have reinsurance programs that have been approved by the federal government.
Republicans and Democratic lawmakers in Connecticut believe the state should apply for a reinsurance waiver, but they differed earlier this year on how to pay for it.
A bill that passed the House and died in the Senate would have used a portion of premium to pay for the reinsurance waiver.
Sen. Kevin Kelly, R-Shelton, has said he believes money from the general fund, about $20 million, should be used to fund the state portion of the reinsurance program, which would cover the costs of the sickest Connecticut residents while keeping down premiums for everyone else.
Lawmakers are currently considering drafting legislation for next year that would include a reinsurance program.
Support authentic, locally owned and operated public service journalism!
A study by Wakely Consulting found that Connecticut could have lowered its premiums by 5% in 2020 if it had gone forward with a reinsurance program. The May 23 study found the state might have been eligible for up to $28.4 million in federal funds to lower premiums 5%.
The study would have required the state to spend $19.2 million to $21.2 million in order to receive the funding, but it didn’t make any assumptions about where the money would come from.
Murphy is not opposed to using the 1332 waiver for reinsurance programs like the one Connecticut is considering.
More Health Care News & Analysis

6 Common Barriers Men Face When Seeking Mental Health Support
The outward effects of mental illness can often be dismissed as a sign of weakness or personal failure. For men, this type of social stereotyping can be especially hard to escape — being told to “man up” is a common refrain that can be reductive and stigmatizing.
Keep readingMedical Examining Board Fines Doctor $10,000
The state Medical Examining Board on Tuesday fined an Oxford doctor $10,000 for fraudulently using another doctor’s name and Drug Enforcement Agency registration number to prescribe controlled substances to a family member.
Keep reading
Clinical Trials With Immunotherapy Drugs Are Source Of Hope And Challenges In Treating Aggressive Breast Cancer
Joshalyn Mills of Branford and Nancy Witz of Kensington had the best possible results after being treated in clinical trials with immunotherapy drugs for aggressive breast cancer: Their tumors were eliminated. But while there are dramatic successes with immunotherapy drugs, there are also many failures, and researchers are trying to find out why in hopes…
Keep reading
Coalition of Health Insurers Questions Viability of Connecticut Partnership Plan
Members of Connecticut’s Health Care Future, a coalition of health insurers, hospitals, and businesses, are questioning whether Connecticut lawmakers have done enough this year to protect teachers and municipal employees from increases in health insurance premiums. “Despite repeated bailouts from taxpayers, the Connecticut Partnership Plan continues to be a fiscal Titanic that demonstrates why government-controlled health…
Keep reading
AG’s Tackle Mental Health Parity
Attorneys General in Connecticut and Rhode Island threw their support Monday behind a coalition of mental health advocacy groups asking a federal appeals court to revisit a recent ruling giving insurance companies more flexibility to deny mental health claims.
Keep reading
Budget Green Lights Psychedelic Therapies
Buried in the budget Gov. Ned Lamont signed this week is a provision that would create a pilot program to allow Connecticut to be the first-in-the-nation to study the impact of psychedelic drugs like psilocybin and MDMA on patients with depression and PTSD. The budget now creates a pilot program within the Department of Mental…
Keep reading